- Home
- CLOV
as 11-10-2025 3:26pm EST
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 1.3B | IPO Year: | N/A |
| Target Price: | $4.23 | AVG Volume (30 days): | 11.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.12 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.12 - $4.87 | Next Earning Date: | 11-04-2025 |
| Revenue: | $1,773,564,000 | Revenue Growth: | 32.15% |
| Revenue Growth (this year): | 40.52% | Revenue Growth (next year): | 31.46% |
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Nov 4 '25 | Sell | $3.58 | 30,385 | $108,778.30 | 2,793,411 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 17 '25 | Sell | $2.69 | 16,514 | $44,422.66 | 2,793,411 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Oct 7 '25 | Sell | $2.65 | 2,012 | $5,331.80 | 2,793,411 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Sep 17 '25 | Sell | $3.09 | 4,914 | $15,184.26 | 2,793,411 | |
| Loengard Anna U | CLOV | N/A | Aug 13 '25 | Buy | $2.59 | 26,500 | $68,755.00 | 27,600 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
GlobeNewswire
11 days ago
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
GlobeNewswire
12 days ago
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
Insider Monkey
15 days ago
Clover Health (CLOV) Soars 41% as Analyst Goes “Buy”
Simply Wall St.
a month ago
Clover Health (CLOV): Assessing Valuation as Shares Show Modest Recovery
Simply Wall St.
a month ago
How Recent Developments Are Shaping the Story Behind Clover Health Investments
GlobeNewswire
a month ago
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
StockStory
a month ago
2 Unprofitable Stocks to Target This Week and 1 Facing Challenges
GlobeNewswire
a month ago
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Compare CLOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.